Claudia Bossen

5PUBLICATIONS
85CO-AUTHORS
Molecular targetsCellular immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 22, 2026
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy.

|Mar 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro

|Oct 08, 2021
The expansion of human T-bethighCD21low B cells is T cell dependent.

Baerbel Keller, Valentina Strohmeier, Ina Harder

|Jun 17, 2018
ZNF341 controls STAT3 expression and thereby immunocompetence.

Stefanie Frey-Jakobs, Julia M Hartberger, Manfred Fliegauf

Pageof 1